《实验与临床癌症研究杂志》寻求包括基础癌症研究重大进展的手稿，并提供从实验室到诊所的转化桥梁，为理解、预防、诊断和治疗癌症开辟新途径。具体的关注领域包括但不限于：恶性表型和转移性疾病的进展机制；预测对治疗的反应或抗药性的分子改变或生物标志物；目标疗法中的翻译研究；个性化医学；生物信息学和生物统计学的新应用；肿瘤免疫治疗；人类肿瘤的大规模分子表征和具有临床应用潜力的创新方法。以下标准概述了该期刊所考虑的研究类型：该研究发现，以前没有在同一个肿瘤模型中发表过。在多个细胞系中进行的研究。这些结论并不代表渐进的研究结果。研究包括明确的标题和摘要，向非专家传达研究的重要性。《实验与临床癌症研究杂志》的在线出现使人们能够立即发表可接受的文章，并提供大量数据和补充信息，以确保新的研究尽可能高效和迅速地传播到科学界。
https://www.editorialmanager.com/jecc/default.aspx
Journal of Experimental & Clinical Cancer Research seeks manuscripts that include significant advances in basic cancer research and that offer a translational bridge from the laboratory to the clinic to open new avenues for the understanding, prevention, diagnosis and treatment of cancer.Specific areas of interest include, but are not limited to: mechanisms of progression of the malignant phenotype and metastatic disease; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical investigation.The following criteria provide an overview of the types of studies considered by the journal:Findings that have not been previously published in the same tumor model.Studies performed in multiple cell lines.Conclusions that are not representative of incremental findings.Studies that include a clearly written title and abstract that communicate the study's impact of significance to non-experts.The online appearance of Journal of Experimental & Clinical Cancer Research allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.
